S. Lehrian

发表

Metabolic markers distinguish COVID-19 from other intensive care patients and show potential to stratify for disease risk

J. Rupp, A. Katalinic, C. Sina, 2021, medRxiv.

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees

S. Antinori, M. Corbellino, G. Vidarsson, 2022, bioRxiv.

One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk

S. Niemann, J. Rupp, A. Katalinic, 2022, Science advances.

Cohort-based surveillance of SARS-CoV2 transmission mirrors infection rates at the population level: a one-year longitudinal study

H. Busch, S. Niemann, J. Rupp, 2021, medRxiv.

Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients

U. Günther, C. Sina, Alvaro Mallagaray, 2021, Frontiers in Molecular Biosciences.

Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions

K. Moremen, M. Ehlers, S. Lehrian, 2020, The Journal of allergy and clinical immunology.

mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine

C. Sina, J. Nouta, M. Wuhrer, 2023, Frontiers in Immunology.

The BioNTech / Pfizer vaccine BNT162b2 induces class-switched SARS-CoV-2-specific plasma cells and potential memory B cells as well as IgG and IgA serum and IgG saliva antibodies upon the first immunization

M. Ehlers, S. Lehrian, A. S. Lixenfeld, 2021, medRxiv.

Sialylation of IgE reduces FcεRIα interaction and mast cell and basophil activation in vitro and increases IgE half‐life in vivo

U. Jappe, V. Blanchard, M. Ehlers, 2023, Allergy. European Journal of Allergy and Clinical Immunology.

P114 Ionising radiation inhibits inflammation in patients with musculoskeletal diseases: radon treatment vs low-dose radiation therapy

D. Kraft, C. Fournier, B. Frey, 2018 .

Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination.

J. Nouta, S. Lehrian, T. Pongracz, 2024, Allergy.